BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32866246)

  • 1. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Hiram R; Xiong F; Naud P; Xiao J; Sirois M; Tanguay JF; Tardif JC; Nattel S
    Cardiovasc Res; 2021 Jun; 117(7):1776-1789. PubMed ID: 32866246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inflammation resolution-promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction.
    Hiram R; Xiong F; Naud P; Xiao J; Sosnowski DK; Le Quilliec E; Saljic A; Abu-Taha IH; Kamler M; LeBlanc CA; Al-U'Datt DGF; Sirois MG; Hebert TE; Tanguay JF; Tardif JC; Dobrev D; Nattel S
    Cardiovasc Res; 2024 Mar; 120(4):345-359. PubMed ID: 38091977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An N-/L-type calcium channel blocker, cilnidipine, suppresses autonomic, electrical, and structural remodelling associated with atrial fibrillation.
    Tajiri K; Guichard JB; Qi X; Xiong F; Naud P; Tardif JC; Costa AD; Aonuma K; Nattel S
    Cardiovasc Res; 2019 Dec; 115(14):1975-1985. PubMed ID: 31119260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 10 Treatment Ameliorates High-Fat Diet-Induced Inflammatory Atrial Remodeling and Fibrillation.
    Kondo H; Abe I; Gotoh K; Fukui A; Takanari H; Ishii Y; Ikebe Y; Kira S; Oniki T; Saito S; Aoki K; Tanino T; Mitarai K; Kawano K; Miyoshi M; Fujinami M; Yoshimura S; Ayabe R; Okada N; Nagano Y; Akioka H; Shinohara T; Akiyoshi K; Masaki T; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Circ Arrhythm Electrophysiol; 2018 May; 11(5):e006040. PubMed ID: 29748196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease.
    Hiram R; Naud P; Xiong F; Al-U'datt D; Algalarrondo V; Sirois MG; Tanguay JF; Tardif JC; Nattel S
    J Am Coll Cardiol; 2019 Sep; 74(10):1332-1347. PubMed ID: 31488271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation.
    Li LY; Lou Q; Liu GZ; Lv JC; Yun FX; Li TK; Yang W; Zhao HY; Zhang L; Bai N; Zhan CC; Yu J; Zang YX; Li WM
    Eur J Pharmacol; 2020 Aug; 881():173120. PubMed ID: 32325147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
    Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model.
    Zhao Z; Chen Y; Li W; Wang X; Li J; Yang W; Cheng L; Liu T; Liu E; Li G
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):863-71. PubMed ID: 27118660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model.
    Wu Q; Liu H; Liao J; Zhao N; Tse G; Han B; Chen L; Huang Z; Du Y
    Biomed Pharmacother; 2020 Sep; 129():110384. PubMed ID: 32554248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial cardiomyocytes contribute to the inflammatory status associated with atrial fibrillation in right heart disease.
    Le Quilliec E; LeBlanc CA; Neuilly O; Xiao J; Younes R; Altuntas Y; Xiong F; Naud P; Villeneuve L; Sirois MG; Tanguay JF; Tardif JC; Hiram R
    Europace; 2024 Mar; 26(4):. PubMed ID: 38546222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
    Luo B; Han F; Xu K; Wang J; Liu Z; Shen Z; Li J; Liu Y; Jiang M; Zhang ZY; Zhang Z
    J Neurosci; 2016 Sep; 36(37):9590-603. PubMed ID: 27629711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation.
    Hesselkilde EZ; Carstensen H; Flethøj M; Fenner M; Kruse DD; Sattler SM; Tfelt-Hansen J; Pehrson S; Braunstein TH; Carlson J; Platonov PG; Jespersen T; Buhl R
    BMC Cardiovasc Disord; 2019 Oct; 19(1):228. PubMed ID: 31638896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhodiola Inhibits Atrial Arrhythmogenesis in a Heart Failure Model.
    Liu SH; Hsiao YW; Chong E; Singhal R; Fong MC; Tsai YN; Hsu CP; Chen YC; Chen YJ; Chiou CW; Chiang SJ; Chang SL; Chen SA
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1093-101. PubMed ID: 27255210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remodelling in atrial fibrillation: the impact of amiodarone.
    Grosu AI; Radulescu D; Grosu LC; Pop D
    Cardiovasc J Afr; 2019 May/Jun 23; 30(3):174-180. PubMed ID: 31140543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease.
    Dai C; Kong B; Shuai W; Xiao Z; Qin T; Fang J; Gong Y; Zhu J; Liu Q; Fu H; Meng H; Huang H
    ESC Heart Fail; 2023 Feb; 10(1):578-593. PubMed ID: 36369767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties.
    Ma J; Ma S; Yin C; Wu H
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):616-627. PubMed ID: 29377366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice.
    Mighiu AS; Recalde A; Ziberna K; Carnicer R; Tomek J; Bub G; Brewer AC; Verheule S; Shah AM; Simon JN; Casadei B
    Cardiovasc Res; 2021 Sep; 117(11):2354-2364. PubMed ID: 33483749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolocumab prevents atrial fibrillation in rheumatoid arthritis rats through restraint of PCSK9 induced atrial remodeling.
    Han X; Gao Y; He M; Luo Y; Wei Y; Duan Y; Zhang S; Yu H; Kan J; Hou T; Zhang Y; Li Y
    J Adv Res; 2024 Jul; 61():211-221. PubMed ID: 37709197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats.
    Zhang K; Ma Z; Wang W; Liu R; Zhang Y; Yuan M; Li G
    Cardiovasc Ther; 2018 Dec; 36(6):e12466. PubMed ID: 30203914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.